New concepts on diabetic retinopathy: Neural versus vascular damage;Novos conceitos em retinopatia diabética: Dano neurológico versus dano vascular

Arquivos Brasileiros de Oftalmologia

Volumn 71, Issue 3, 2008, Pages 459-463

  Serrarbassa, Pedro Durães ^a,b   Gomes Dias, Alana Ferreira ^b   Vieira, Marcio Fragoso ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apoptosis; Diabetic retinopathy etiology; Nerve degeneration; Vascular diseases; Vision physiology

Indexed keywords

DEGENERATIVE DISEASE; DIABETIC RETINOPATHY; HUMAN; REVIEW; TIME; VASCULAR DISEASE;

DIABETIC RETINOPATHY; HUMANS; NEURODEGENERATIVE DISEASES; TIME FACTORS; VASCULAR DISEASES;

EID: 62149152441     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492008000300030     Document Type: Article

References (58)

1. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520-6.
2. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(2):283-90. Comment in: Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(4):747-8; author reply 745-6.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. Comment in: Diabetes Care. 2004;27(10):2568-9; author reply 2569.
4. Cunha-Vaz J, Faria de Abreu JR, Campos AJ. Early breakdown of the bloodretinal barrier in diabetes. Br J Ophthalmol. 1975;59(11):649-56.
5. rd, et al. Diabetic retinopathy. Diabetes Care. 1998;21(1):143-56.
6. Moss SE, Klein R, Klein BE. The incidence of vision loss in a diabetic population. Ophthalmology. 1988;95(10):1340-8.
7. Gillies M. When does neural degeneration occur in diabetic retinopathy? Clin Experiment Ophthalmol. 2000;28(1):1-2. Comment on: Clin Experiment Ophthalmol. 2000;28(1):3-8
8. Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, Kester M, Kimball SR, Krady JK, LaNoue KF, Norbury CC, Quinn PG, Sandirasegarane L, Simpson IA; JDRF Diabetic Retinopathy Center Group. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes. 2006;55(9):2401-11.
9. Bito LZ, Salvador EV, Petrinovic L. Intraocular fluid dynamics. IV. Intraocular sites of solute utilization and transport as revealed by studies on aphakic eyes. Exp Eye Res. 1978;26(1):47-55.
10. Masland RH. The fundamental plan of the retina. Nat Neurosci. 2001;4(9):877-86.
11. Gardner TW, Lieth E, Khin SA, Barber AJ, Bonsall DJ, Lesher T, et al. Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. Invest Ophthalmol Vis Sci. 1997;38(11):2423-7.
12. Newman EA. New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci. 2003;26(10):536-42.
13. Lieth E, LaNoue KF, Berkich DA, Xu B, Ratz M, Taylor C, et al. Nitrogen shuttling between neurons and glial cells during glutamate synthesis. J Neurochem. 2001;76(6):1712-23.
14. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85(3):845-81.
15. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes. 2005;54(5):1559-65.
16. Elward K, Gasque P. "Eat me" and "don't eat me" signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. Mol Immunol. 2003;40(2-4):85-94.
17. Fetler L, Amigorena S. Neuroscience. Brain under surveillance: the microglia patrol. Science. 2005;309(5733):392-3.
18. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726): 1314-8.
19. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol. 2002;47(Suppl 2): S253-62.
20. Bristow EA, Griffiths PG, Andrews RM, Johnson MA, Turnbull DM. The distribution of mitochondrial activity in relation to optic nerve structure. Arch Ophthalmol. 2002;120(6):791-6.
21. Comment in: Arch Ophthalmol. 2003;121 (9):1342-3.
22. Wangsa-Wirawan ND, Linsenmeier RA. Retinal oxygen: fundamental and clinical aspects. Arch Ophthalmol. 2003;121(4):547-57.
23. Germer A, Biedermann B, Wolburg H, Schuck J, Grosche J, Kuhrt H, et al. Distribution of mitochondria within Muller cells-I. Correlation with retinal vascularization in different mammalian species. J Neurocytol. 1998;27(5):329-45.
24. Lieth E, Gardner TW, Barber AJ, Antonetti DA; Penn State Retina Research Group. Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol. 2000;28(1):3-8. Comment in: Clin Experiment Ophthalmol. 2000;28(1):1-2.
25. Bloodworth JM Jr. Diabetic retinopathy. Diabetes. 1962;11:1-22.
26. Wolter JR. Diabetic retinopathy. Am J Ophthalmol. 1961;51:1123-41.
27. Bearse MA Jr, Han Y, Schneck ME, Barez S, Jacobsen C, Adams AJ. Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45(9):3259-65.
28. Bresnick GH. Diabetic retinopathy viewed as a neurosensory disorder. Arch Ophthalmol. 1986;104(7):989-90.
29. Ghirlanda G, Di Leo MA, Caputo S, Cercone S, Greco AV. From functional to microvascular abnormalities in early diabetic retinopathy. Diabetes Metab Rev. 1997;13(1):15-35.
30. Greenstein VC, Shapiro A, Zaidi Q, Hood DC. Psychophysical evidence for post-receptoral sensitivity loss in diabetics. Invest Ophthalmol Vis Sci. 1992; 33(10):2781-90.
31. Parisi V, Uccioli L. Visual electrophysiological responses in persons with type 1 diabetes. Diabetes Metab Res Rev. 2001;17(1):12-8.
32. Bresnick GH, Palta M. Predicting progression to severe proliferative diabetic retinopathy. Arch Ophthalmol. 1987;105(6):810-4.
33. Han Y, Adams AJ, Bearse MA Jr, Schneck ME. Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy. Arch Ophthalmol. 2004;122(12):1809-15.
34. Bengtsson B, Heijl A, Agardh E. Visual fields correlate better than visual acuity to severity of diabetic retinopathy. Diabetologia. 2005;48(12):2494-500.
35. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111-9.
36. Schroder S, Palinski W, Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol. 1991;139(1):81-100.
37. Caicedo A, Espinosa-Heidmann DG, Piña Y, Hernandez EP, Cousins SW. Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization. Exp Eye Res. 2005; 81(1):38-47.
38. Barber AJ, Nakamura M, Wolpert EB, Reiter CE, Seigel GM, Antonetti DA, et al. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3. J Biol Chem. 2001;276(35):32814-21.
39. Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature. 2005;438(7070):960-6.
40. Seigel GM, Chiu L, Paxhia A. Inhibition of neuroretinal cell death by insulin-like growth factor-1 and its analogs. Mol Vis. 2000;6:157-63.
41. Hammes HP, Federoff HJ, Brownlee M. Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med. 1995;1(5):527-34.
42. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol. 1997;115(8):1031-5.
43. Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest. 1996;97(12):2883-90.
44. Mohr S, Xi X, Tang J, Kern TS. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes. 2002;51(4):1172-9.
45. Podesta F, Romeo G, Liu WH, Krajewski S, Reed JC, Gerhardinger C, et al. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol. 2000;156(3):1025-32.
46. Plum L, Schubert M, Bruning JC. The role of insulin receptor signaling in the brain. Trends Endocrinol Metab. 2005;16(2):59-65.
47. Reiter CE, Wu X, Sandirasegarane L, Nakamura M, Gilbert KA, Singh RS, et al. Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin. Diabetes. 2006;55(4):1148-56.
48. Yi X, Schubert M, Peachey NS, Suzuma K, Burks DJ, Kushner JA, et al. Insulin receptor substrate 2 is essential for maturation and survival of photoreceptor cells. J Neurosci. 2005;25(5):1240-8.
49. Barber AJ, Nakamura M, Wolpert EB, Reiter CE, Seigel GM, Antonetti DA, et al. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3. J Biol Chem. 2001;276(35):32814-21.
50. Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, et al. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest. 2003;111(12):1835-42. Comment in: J Clin Invest. 2003;111(12):1817-9.
51. Chihara E. Impairment of protein synthesis in the retinal tissue in diabetic rabbits: secondary reduction of fast axonal transport. J Neurochem. 1981;37(1):247-50.
52. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44(8):968-83.
53. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest. 1998;102(4):783-91.
54. Li Q, Puro DG. Diabetes-induced dysfunction of the glutamate transporter in retinal Muller cells. Invest Ophthalmol Vis Sci. 2002;43(9):3109-16.
55. Varkonyi TT, Peto T, Degi R, Keresztes K, Lengyel C, Janaky M, et al. Impairment of visual evoked potentials: an early central manifestation of diabetic neuropathy? Diabetes Care. 2002;25(9):1661-2.
56. Chihara E, Matsuoka T, Ogura Y, Matsumura M. Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy. Ophthalmology. 1993; 100(8):1147-51.
57. Ozdek S, Lonneville YH, Onol M, Yetkin I, Hasanreisoglu BB. Assessment of nerve fiber layer in diabetic patients with scanning laser polarimetry. Eye. 2002;16(6):761-5.
58. Han Y, Bearse MA Jr, Schneck ME, Barez S, Jacobsen CH, Adams AJ. Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45(3):948-54. Comment in: ACP J Club. 1994;120 (Suppl 2):30-1; N Engl J Med. 1993;329(14):1035-6; N Engl J Med. 1994;330 (9):641-2; N Engl J Med. 1994;330(9):641; author reply 642. N Engl J Med. 1994;330(9):642; N Engl J Med. 2006;354(16):1751-2; author reply 1751-2.